End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
263.5 TWD | +1.35% | +2.53% | +44.38% |
05-03 | Topco Scientific Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-16 | Taiwan appoints senior executive at TSMC supplier as new economy minister | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Semiconductors
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+44.38% | 1.55B | - | ||
+90.51% | 2,321B | B- | ||
+41.82% | 678B | A- | ||
+26.53% | 654B | C | ||
+10.35% | 263B | B- | ||
+33.60% | 216B | B- | ||
+14.40% | 178B | A- | ||
+49.85% | 142B | B+ | ||
-36.24% | 136B | C+ | ||
+52.00% | 119B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 5434 Stock
- Ratings Topco Scientific Co.,Ltd.